Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Contact system activation during erythema marginatum in hereditary angioedema.

Nguyen A, Zuraw BL, Christiansen SC.

Ann Allergy Asthma Immunol. 2020 Jan 23. pii: S1081-1206(20)30014-4. doi: 10.1016/j.anai.2020.01.009. [Epub ahead of print] No abstract available.

PMID:
31981614
2.

Treatment of Hypertension in Patients with Asthma. Reply.

Christiansen SC, Zuraw BL.

N Engl J Med. 2019 Dec 5;381(23):2279. doi: 10.1056/NEJMc1913646. No abstract available.

PMID:
31801005
3.

Treatment of Hypertension in Patients with Asthma.

Christiansen SC, Zuraw BL.

N Engl J Med. 2019 Sep 12;381(11):1046-1057. doi: 10.1056/NEJMra1800345. Review. No abstract available.

PMID:
31509675
4.
5.

Development of a health-related quality of life instrument for patients with hereditary angioedema living in the United States.

Busse PJ, Christiansen SC, Birmingham JM, Overbey JR, Banerji A, Otani IM, Lumry W, Goryachkovsky A, Zuraw BL.

J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1679-1683.e7. doi: 10.1016/j.jaip.2018.11.042. Epub 2018 Dec 12. No abstract available.

PMID:
30550806
6.

Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial.

Banerji A, Riedl MA, Bernstein JA, Cicardi M, Longhurst HJ, Zuraw BL, Busse PJ, Anderson J, Magerl M, Martinez-Saguer I, Davis-Lorton M, Zanichelli A, Li HH, Craig T, Jacobs J, Johnston DT, Shapiro R, Yang WH, Lumry WR, Manning ME, Schwartz LB, Shennak M, Soteres D, Zaragoza-Urdaz RH, Gierer S, Smith AM, Tachdjian R, Wedner HJ, Hebert J, Rehman SM, Staubach P, Schranz J, Baptista J, Nothaft W, Maurer M; HELP Investigators.

JAMA. 2018 Nov 27;320(20):2108-2121. doi: 10.1001/jama.2018.16773. Erratum in: JAMA. 2019 Apr 23;321(16):1636.

7.

Angioedema Due to Bradykinin Dysregulation.

Cicardi M, Zuraw BL.

J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1132-1141. doi: 10.1016/j.jaip.2018.04.022. Review.

PMID:
30033914
8.

Threshold-stimulated kallikrein activity distinguishes bradykinin- from histamine-mediated angioedema.

Lara-Marquez ML, Christiansen SC, Riedl MA, Herschbach J, Zuraw BL.

Clin Exp Allergy. 2018 Nov;48(11):1429-1438. doi: 10.1111/cea.13219. Epub 2018 Aug 21.

PMID:
29957871
9.

Hereditary angioedema with normal C1 inhibitor: Four types and counting.

Zuraw BL.

J Allergy Clin Immunol. 2018 Mar;141(3):884-885. doi: 10.1016/j.jaci.2018.01.015. Epub 2018 Feb 2. No abstract available.

PMID:
29410040
10.

Laboratory Approaches for Assessing Contact System Activation.

Christiansen SC, Zuraw BL.

Immunol Allergy Clin North Am. 2017 Aug;37(3):527-539. doi: 10.1016/j.iac.2017.04.008. Review.

PMID:
28687107
11.

Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor.

Longhurst H, Cicardi M, Craig T, Bork K, Grattan C, Baker J, Li HH, Reshef A, Bonner J, Bernstein JA, Anderson J, Lumry WR, Farkas H, Katelaris CH, Sussman GL, Jacobs J, Riedl M, Manning ME, Hebert J, Keith PK, Kivity S, Neri S, Levy DS, Baeza ML, Nathan R, Schwartz LB, Caballero T, Yang W, Crisan I, Hernandez MD, Hussain I, Tarzi M, Ritchie B, Králíčková P, Guilarte M, Rehman SM, Banerji A, Gower RG, Bensen-Kennedy D, Edelman J, Feuersenger H, Lawo JP, Machnig T, Pawaskar D, Pragst I, Zuraw BL; COMPACT Investigators.

N Engl J Med. 2017 Mar 23;376(12):1131-1140. doi: 10.1056/NEJMoa1613627.

12.

Anabolic androgen use in the management of hereditary angioedema: Not so cheap after all.

Tse KY, Zuraw BL, Chen Q, Christiansen SC.

Ann Allergy Asthma Immunol. 2017 Apr;118(4):456-460.e1. doi: 10.1016/j.anai.2017.01.015. Epub 2017 Mar 7.

PMID:
28283277
13.

Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease.

Eastman JJ, Cavagnero KJ, Deconde AS, Kim AS, Karta MR, Broide DH, Zuraw BL, White AA, Christiansen SC, Doherty TA.

J Allergy Clin Immunol. 2017 Jul;140(1):101-108.e3. doi: 10.1016/j.jaci.2016.11.023. Epub 2017 Mar 6.

14.

Subcutaneous Icatibant for the Treatment of Hereditary Angioedema Attacks: Comparison of Home Self-Administration with Administration at a Medical Facility.

Otani IM, Lumry WR, Hurwitz S, Li HH, Craig TJ, Holtzman NS, Iandoli MI, Tucker J, Riedl MA, Zuraw BL, Banerji A.

J Allergy Clin Immunol Pract. 2017 Mar - Apr;5(2):442-447.e1. doi: 10.1016/j.jaip.2016.09.023. Epub 2016 Nov 3.

PMID:
27818136
15.

Emergency Department Management of Hereditary Angioedema Attacks: Patient Perspectives.

Otani IM, Christiansen SC, Busse P, Camargo CA Jr, Zuraw BL, Riedl MA, Banerji A.

J Allergy Clin Immunol Pract. 2017 Jan - Feb;5(1):128-134.e4. doi: 10.1016/j.jaip.2016.06.029. Epub 2016 Sep 21.

PMID:
27665386
16.

HAE Pathophysiology and Underlying Mechanisms.

Zuraw BL, Christiansen SC.

Clin Rev Allergy Immunol. 2016 Oct;51(2):216-29. doi: 10.1007/s12016-016-8561-8. Review.

PMID:
27459852
17.

Tolerability and Effectiveness of 17-α-Alkylated Androgen Therapy for Hereditary Angioedema: A Re-examination.

Zuraw BL, Davis DK, Castaldo AJ, Christiansen SC.

J Allergy Clin Immunol Pract. 2016 Sep-Oct;4(5):948-955.e15. doi: 10.1016/j.jaip.2016.03.024. Epub 2016 Jun 18.

PMID:
27329469
18.

How we manage persons with hereditary angioedema.

Zuraw BL, Christiansen SC.

Br J Haematol. 2016 Jun;173(6):831-43. doi: 10.1111/bjh.14059. Epub 2016 Apr 12. Review.

PMID:
27071490
19.

Pediatric Hereditary Angioedema: Onset, Diagnostic Delay, and Disease Severity.

Christiansen SC, Davis DK, Castaldo AJ, Zuraw BL.

Clin Pediatr (Phila). 2016 Sep;55(10):935-42. doi: 10.1177/0009922815616886. Epub 2015 Nov 18.

PMID:
26581355
20.

Hypertension and Asthma: A Comorbid Relationship.

Christiansen SC, Schatz M, Yang SJ, Ngor E, Chen W, Zuraw BL.

J Allergy Clin Immunol Pract. 2016 Jan-Feb;4(1):76-81. doi: 10.1016/j.jaip.2015.07.009. Epub 2015 Sep 3.

PMID:
26342745
21.

Rhinovirus infection interferes with induction of tolerance to aeroantigens through OX40 ligand, thymic stromal lymphopoietin, and IL-33.

Mehta AK, Duan W, Doerner AM, Traves SL, Broide DH, Proud D, Zuraw BL, Croft M.

J Allergy Clin Immunol. 2016 Jan;137(1):278-288.e6. doi: 10.1016/j.jaci.2015.05.007. Epub 2015 Jun 19.

22.

Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrate.

Zuraw BL, Cicardi M, Longhurst HJ, Bernstein JA, Li HH, Magerl M, Martinez-Saguer I, Rehman SM, Staubach P, Feuersenger H, Parasrampuria R, Sidhu J, Edelman J, Craig T.

Allergy. 2015 Oct;70(10):1319-28. doi: 10.1111/all.12658. Epub 2015 Aug 11.

23.

Current state of hereditary angioedema management: a patient survey.

Banerji A, Busse P, Christiansen SC, Li H, Lumry W, Davis-Lorton M, Bernstein JA, Frank M, Castaldo A, Long JF, Zuraw BL, Riedl M.

Allergy Asthma Proc. 2015 May-Jun;36(3):213-7. doi: 10.2500/aap.2015.36.3824.

24.

Before and after, the impact of available on-demand treatment for HAE.

Christiansen SC, Bygum A, Banerji A, Busse P, Li H, Lumry W, Davis-Lorton M, Bernstein JA, Frank MM, Castaldo A, Long JF, Riedl M, Zuraw BL.

Allergy Asthma Proc. 2015 Mar-Apr;36(2):145-50. doi: 10.2500/aap.2015.36.3831.

PMID:
25715243
25.

A consensus parameter for the evaluation and management of angioedema in the emergency department.

Moellman JJ, Bernstein JA, Lindsell C, Banerji A, Busse PJ, Camargo CA Jr, Collins SP, Craig TJ, Lumry WR, Nowak R, Pines JM, Raja AS, Riedl M, Ward MJ, Zuraw BL, Diercks D, Hiestand B, Campbell RL, Schneider S, Sinert R; American College of Allergy, Asthma & Immunology (ACAAI); Society for Academic Emergency Medicine (SAEM).

Acad Emerg Med. 2014 Apr;21(4):469-84. doi: 10.1111/acem.12341.

26.

US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency.

Zuraw BL, Banerji A, Bernstein JA, Busse PJ, Christiansen SC, Davis-Lorton M, Frank MM, Li HH, Lumry WR, Riedl M; US Hereditary Angioedema Association Medical Advisory Board.

J Allergy Clin Immunol Pract. 2013 Sep-Oct;1(5):458-67. doi: 10.1016/j.jaip.2013.07.002. Epub 2013 Aug 30.

PMID:
24565617
27.

Current update on cellular and molecular mechanisms of hereditary angioedema.

Walford HH, Zuraw BL.

Ann Allergy Asthma Immunol. 2014 May;112(5):413-8. doi: 10.1016/j.anai.2013.12.023. Epub 2014 Jan 29. Review.

PMID:
24484972
28.

Immunology and Allergy Clinics of North America. Angioedema. Preface.

Zuraw BL.

Immunol Allergy Clin North Am. 2013 Nov;33(4):xi-xiii. doi: 10.1016/j.iac.2013.09.002. No abstract available.

PMID:
24176220
29.

Rare disease partnership: the role of the US HAEA in angioedema care.

Zuraw BL, Christiansen SC.

Immunol Allergy Clin North Am. 2013 Nov;33(4):545-53. doi: 10.1016/j.iac.2013.07.011. Epub 2013 Aug 24. Review.

PMID:
24176218
30.

A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema.

Zuraw BL, Bernstein JA, Lang DM, Craig T, Dreyfus D, Hsieh F, Khan D, Sheikh J, Weldon D, Bernstein DI, Blessing-Moore J, Cox L, Nicklas RA, Oppenheimer J, Portnoy JM, Randolph CR, Schuller DE, Spector SL, Tilles SA, Wallace D; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology.

J Allergy Clin Immunol. 2013 Jun;131(6):1491-3. doi: 10.1016/j.jaci.2013.03.034.

PMID:
23726531
31.

Recognizing and managing hereditary angioedema.

Tse K, Zuraw BL.

Cleve Clin J Med. 2013 May;80(5):297-308. doi: 10.3949/ccjm.80a.12073. Review.

32.

Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study.

Riedl MA, Levy RJ, Suez D, Lockey RF, Baker JW, Relan A, Zuraw BL.

Ann Allergy Asthma Immunol. 2013 Apr;110(4):295-9. doi: 10.1016/j.anai.2013.02.007. Epub 2013 Mar 6.

PMID:
23535096
33.

Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel.

Zuraw BL, Bork K, Binkley KE, Banerji A, Christiansen SC, Castaldo A, Kaplan A, Riedl M, Kirkpatrick C, Magerl M, Drouet C, Cicardi M.

Allergy Asthma Proc. 2012 Nov-Dec;33 Suppl 1:S145-56. doi: 10.2500/aap.2012.33.3627.

PMID:
23394603
34.

Safety and efficacy of prophylactic nanofiltered C1-inhibitor in hereditary angioedema.

Zuraw BL, Kalfus I.

Am J Med. 2012 Sep;125(9):938.e1-7. doi: 10.1016/j.amjmed.2012.02.020. Epub 2012 Jul 14.

PMID:
22800873
35.

Hereditary angioedema: management of laryngeal attacks.

Christiansen SC, Zuraw BL.

Am J Rhinol Allergy. 2011 Nov-Dec;25(6):379-82. doi: 10.2500/ajra.2011.25.3670. Review.

PMID:
22185739
36.

Pathophysiology of hereditary angioedema.

Zuraw BL, Christiansen SC.

Am J Rhinol Allergy. 2011 Nov-Dec;25(6):373-8. doi: 10.2500/ajra.2011.25.3661. Review.

PMID:
22185738
37.

Safety and efficacy of physician-supervised self-managed C1 inhibitor replacement therapy.

Tourangeau LM, Castaldo AJ, Davis DK, Koziol J, Christiansen SC, Zuraw BL.

Int Arch Allergy Immunol. 2012;157(4):417-24. doi: 10.1159/000329635. Epub 2011 Nov 25.

38.

Abstracts from the North American Rhinology & Allergy Conference, February 3, 2011, Puerto Rico.

Carr WW, Bernstein DI, Hampel FC, Gow JA, Williams JI, Zuraw BL, Chipps BE, Miller TA, Berger WE, Carr WW, Tort MJ.

Am J Rhinol Allergy. 2011 Sep 1;25(5):369. doi: 10.2500/ajra.2011.11.3699.

PMID:
29021069
39.

The new era of C1-esterase inhibitor deficiency therapy.

Tourangeau LM, Zuraw BL.

Curr Allergy Asthma Rep. 2011 Oct;11(5):345-51. doi: 10.1007/s11882-011-0213-8. Review.

PMID:
21833753
40.

The association of obesity and asthma severity and control in children.

Quinto KB, Zuraw BL, Poon KY, Chen W, Schatz M, Christiansen SC.

J Allergy Clin Immunol. 2011 Nov;128(5):964-9. doi: 10.1016/j.jaci.2011.06.031. Epub 2011 Aug 6.

PMID:
21820711
41.

The tumor necrosis factor family member LIGHT is a target for asthmatic airway remodeling.

Doherty TA, Soroosh P, Khorram N, Fukuyama S, Rosenthal P, Cho JY, Norris PS, Choi H, Scheu S, Pfeffer K, Zuraw BL, Ware CF, Broide DH, Croft M.

Nat Med. 2011 May;17(5):596-603. doi: 10.1038/nm.2356. Epub 2011 Apr 17.

42.

Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema.

Zuraw BL, Busse PJ, White M, Jacobs J, Lumry W, Baker J, Craig T, Grant JA, Hurewitz D, Bielory L, Cartwright WE, Koleilat M, Ryan W, Schaefer O, Manning M, Patel P, Bernstein JA, Friedman RA, Wilkinson R, Tanner D, Kohler G, Gunther G, Levy R, McClellan J, Redhead J, Guss D, Heyman E, Blumenstein BA, Kalfus I, Frank MM.

N Engl J Med. 2010 Aug 5;363(6):513-22. doi: 10.1056/NEJMoa0805538.

44.

The pathophysiology of hereditary angioedema.

Zuraw BL.

World Allergy Organ J. 2010 Sep;3(9 Suppl):S25-8. doi: 10.1097/WOX.0b013e3181f3f21c.

45.
46.

HAE therapies: past present and future.

Zuraw BL.

Allergy Asthma Clin Immunol. 2010 Jul 28;6(1):23. doi: 10.1186/1710-1492-6-23.

47.

Cigarette smoke decreases innate responses of epithelial cells to rhinovirus infection.

Eddleston J, Lee RU, Doerner AM, Herschbach J, Zuraw BL.

Am J Respir Cell Mol Biol. 2011 Jan;44(1):118-26. doi: 10.1165/rcmb.2009-0266OC. Epub 2010 Mar 11.

49.

Update on therapeutic developments for hereditary angioedema.

Christiansen SC, Zuraw BL.

Allergy Asthma Proc. 2009 Sep-Oct;30(5):500-5. doi: 10.2500/aap.2009.30.3282. Review.

PMID:
19843404
50.

Pathogenesis and laboratory diagnosis of hereditary angioedema.

Zuraw BL, Christiansen SC.

Allergy Asthma Proc. 2009 Sep-Oct;30(5):487-92. doi: 10.2500/aap.2009.30.3277.

PMID:
19843402

Supplemental Content

Loading ...
Support Center